Phase 3 Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 70 years old (both ages included), and any gender may apply
- You have been officially diagnosed with silicosis or coal worker's pneumoconiosis according to Chinese occupational disease diagnostic standards
- Your lung breathing capacity (FVC) is between 40% and 80% of what would be expected for a healthy person your age
- Your lungs' ability to transfer oxygen into the blood (DLCO) is between 30% and 80% of the expected normal level
- A special type of chest scan (HRCT) shows widespread changes to the tissue throughout your lungs
- You are willing to take part, can follow the study instructions, and are able to read and sign a consent form
Who may not be able to join:
- You have had a lung wash-out procedure (lung lavage) in the last 3 months, or plan to have one during the trial
- Your liver function blood test results are significantly higher than normal (confirm with trial site)
- Your kidney function is significantly reduced (confirm with trial site)
- You have had an infection or high fever in the past 4 weeks, such as chest infection, pneumonia, sinus infection, urinary tract infection, or a skin infection
- You currently have tuberculosis or lung cancer
- You have serious high blood pressure in the lungs or severe right-sided heart failure that your doctor feels makes participation unsafe
- You have had serious heart or blood pressure problems, including very high uncontrolled blood pressure in the last 6 weeks, a heart attack in the last 6 months, or unstable chest pain in the last 6 months
- Your blood clotting test results are significantly above normal (confirm with trial site)
- You have difficulty swallowing, problems absorbing food, or need to be fed through a tube or drip
- You have an active stomach ulcer
- You have had a blood clot, stroke, or mini-stroke in the last 12 months
- You are currently taking certain immune-suppressing or cell-affecting medications, such as methotrexate, cyclosporine, or TNF-alpha inhibitors (confirm with trial site for full list)
- You have taken certain specific lung or related medications within the last month before joining, including nintedanib or high-dose acetylcysteine (confirm with trial site for full list)
- You have previously taken medications that can cause lung scarring (such as amiodarone), or have been exposed to asbestos, beryllium, or radiation
- You are allergic to the study drug or any of its ingredients (including lactose)
- Your doctor believes you have less than 2.5 years to live due to another medical condition
- You have a major operation planned during the time you would be on the trial
- You are pregnant, breastfeeding, or planning to become pregnant during the trial
- You are a woman who could become pregnant but are unwilling or unable to use reliable contraception from 28 days before to 3 months after taking the study drug
- Your doctor believes you have a problem with alcohol or drug misuse
- You have a mental illness
- You have taken part in another clinical drug trial in the last 3 months
- For any other reason, the trial doctor does not think it is safe or suitable for you to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Huaping Dai, Dr, China-Japan Friendship Hospital
Phone: 13501209210
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in pulmonary function FVC%
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.